Every lot listed here comes with peptide certificate of analysis documentation from Freedom Diagnostics, an independent US lab that runs identity, purity, and endotoxin testing separate from GLP Bulk itself. That separation matters, since it means the numbers on each report aren’t self-reported.

The peptide COA documentation on this page breaks down into two parts for each vial: a purity report confirming molecular identity and net peptide content, and an endotoxin report using the LAL method to check for bacterial contamination. Both are published in full rather than summarized, so labs can review the raw data themselves.

What the Numbers Actually Mean

Net peptide content is measured against the labeled amount, so a 10mg vial showing just under 11mg isn’t unusual and reflects standard variance in lyophilized peptide production rather than an error. HPLC-tested research peptides go through this measurement as part of routine batch verification, not as a one-off check.

For compounds like retatrutide reference standard and retatrutide analytical standard material, documentation spans multiple vial sizes and lots, which matters for labs running cross-batch comparisons where consistency between lots affects reproducibility. The same applies to semaglutide reference standard and tirzepatide reference standard listings, where lot numbers are tracked separately so researchers can trace which batch a given result came from.

Why This Matters for Reference Work

Labs using peptide reference standards or analytical peptide standards for calibration work depend on knowing exactly what’s in a vial before it’s used as a comparison point. A COA without underlying lab traceability is just a document. Publishing the full report, lot by lot, is what lets that document actually function as a research tool rather than a formality.